Guest guest Posted July 1, 2005 Report Share Posted July 1, 2005 Can cancer be cured today with the procedure which is indebted to the anticancer research of two of the world's greatest scientists? Medline is www.ncbi.nlm.nih.gov/pubmed; type in the number to see the article. TAC is Thiazolidine-4-carboxylic acid. DOX is known as Doxorubicin, Adriamycin and " The Red Devil " . " DOX is still the most widely used anticancer drug, with the broadest spectrum of antitumor effects... " Medline 8692981 1. Dr. Gosalvez, Director of Spanish Biochemical Research from 1970 to 2000, discovered that TAC caused the " ...disappearance of evidence of cancer. " in a clinical trial. Medline 6101417 2. Dr. V. Schally, a 1977 Nobel Prize winner in Medicine, invented 2-pyrrolinodoxorubicin which is " 500 - 1000 times more potent " than DOX. Medline 8637897 & 8692981 What might be the result of combining TAC & 2-pyrrolinodoxorubicin? Dr. Schally's January, 1997 publication, Medline 9012839, identifies this combination as AN-257 which his laboratory research indicated was many " ...times higher than that of DOX... " in causing the " Inhibition of growth " of these human cancers; refer to Table 3 - a. Pancreatic: AN-257 was 335 " times higher " than DOX b. Small Cell Lung: AN-257 was 1657 " times higher " than DOX c. Prostate: AN-257 was 224 " times higher " than DOX d. Gastric (stomach): AN-257 was 857 " times higher " than DOX. In summary, Dr. Schally's laboratory results indicated that the combination of TAC & 2-pyrrolinodoxorubicin (AN-257) was hundreds of " times higher " than that of DOX in causing the " Inhibition of growth " of pancreatic, small cell lung, prostrate and gastric cancer. With the procedure cancer patients could swallow mega doses of TAC and vitamin C and be injected with 2-pyrrolinodoxorubicin. They could also swallow mushroom extracts which are anti-cancerous according to the U.S. National Cancer Institute. Medline 2672723 S. , 5086 Sunrise Ave., Portage, Indiana 46368, (219) 763-1933 The Cure for Cancer , http://cures for cancer.ws/tac-cure.htm (note the tac) Post Script - To see the TAC in Dr. Schally's January, 1997 report, refer to Table 1., B3. B3 is Dr. Schally's compound RC-3950-II; TAC is the most " important ingredient " in this compound; refer to the concluding sentences of Medline 7809097: " ...The replacement of Phe with Tac in reduced bond BN antagonists produced improved Ki and IC50 values. BN antagonists such as RC-3950-II may have important therapeutic applications for the treatment of various malignancies such as prostatic, gastric, and pancreatic cancer, small cell lung carcinoma, and other tumors. " Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.